Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

J&J withdraws offer to acquire Guidant

Executive Summary

Johnson & Johnson has agreed to acquire Guidant for approximately $25.38bn in cash and stock. Guidant shareholders will receive $30.40 in cash and $45.60 in J&J common stock, a 7% premium. The total consideration per Guidant share may be adjusted if J&J's trading price goes outside an agreed limit in the period before the deal closes.
Deal Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Withdrawn
Deal Type
  • Acquisition
    • Includes Contract
    • Payment Includes Stock
    • Full Acquisition
    • Payment Includes Cash

Related Companies

Advertisement
UsernamePublicRestriction

Register